Congenital cytomegalovirus (cCMV) infection is a common and yet underappreciated cause of hearing loss and neurodevelopment disability in US children.1 Any opportunity to achieve early detection of cCMV and provide interventions warrants careful consideration.

Diener et al2 in this issue document the experience with targeted screening for cCMV in Utah among infants who do not pass newborn hearing screening (NBHS). Since July 2013, Utah has required referral for testing for cytomegalovirus (CMV) within 21 days of birth for newborns who do not pass NBHS and follow-up outpatient screening.3 Most notably, the introduction of targeted screening for cCMV, along with state-funded public education about cCMV, was associated with an increase from 56% to 77% in timely diagnostic audiology follow-up (<90 days) of infants who did not pass NBHS.2 That is important because timely diagnosis and early intervention for sensorineural hearing loss (SNHL) improves long-term language outcomes.4...

You do not currently have access to this content.